GSWM
AGN

Golden State Wealth Management’s Allergan plc AGN Stock Holding History

Golden State Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-143
Closed -$25K – 1027
2020
Q1 		$25K Buy
+143
New +$26.9K 0.01% 471
2019
Q4 		– Sell
-142
Closed -$24K – 1092
2019
Q3 		$24K Buy
142
+1
+0.7% +$163 0.01% 589
2019
Q2 		$23K Sell
141
-350
-71% -$48.5K 0.01% 597
2019
Q1 		$72K Buy
+491
New +$71.2K 0.02% 376

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Golden State Wealth Management's AGN Position: Q2 2020 in Review

Golden State Wealth Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 143 shares — an estimated $25K sold.

Golden State Wealth Management first reported a position in AGN in Q1 2019 and held it in 4 quarters. The position peaked at $72K in Q1 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Golden State Wealth Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Golden State Wealth Management sold 143 Allergan plc shares in Q2 2020, an estimated $25K.
  • Golden State Wealth Management first reported a position in Allergan plc in Q1 2019 and held it in 4 quarters.
  • Golden State Wealth Management's Allergan plc position peaked at $72K in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Golden State Wealth Management's 13F filing for Q2 2020, filed 11 Aug 2020.